BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 10847135)

  • 41. Extrahepatic manifestations of chronic HCV infection.
    Galossi A; Guarisco R; Bellis L; Puoti C
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):65-73. PubMed ID: 17410291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extrahepatic manifestations of infection with hepatitis C virus.
    Mehta S; Levey JM; Bonkovsky HL
    Clin Liver Dis; 2001 Nov; 5(4):979-1008. PubMed ID: 11685805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hematologic syndromes in hepatitis C virus infection].
    Kryczka W; Kisiel E
    Przegl Lek; 2000; 57(11):672-5. PubMed ID: 11293218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin resistance and lichen planus in patients with HCV-infectious liver diseases.
    Nagao Y; Kawasaki K; Sata M
    J Gastroenterol Hepatol; 2008 Apr; 23(4):580-5. PubMed ID: 18397487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Extrahepatic manifestation associated with HCV infection].
    Nagao Y; Sata M
    Nihon Shokakibyo Gakkai Zasshi; 1999 Nov; 96(11):1249-57. PubMed ID: 10586600
    [No Abstract]   [Full Text] [Related]  

  • 46. [Extrahepatic syndromes (vascular manifestations) in patients HCV infection].
    Gembitskiĭ EV; Glazunov AV; Zhiliaev EV; Proskurina TV
    Klin Med (Mosk); 1995; 73(6):51-3. PubMed ID: 8691784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report.
    Shimada M; Nakamura N; Endo T; Yamabe H; Nakamura M; Murakami R; Narita I; Tomita H
    BMC Nephrol; 2017 Mar; 18(1):109. PubMed ID: 28356063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hepatitis C virus and resulting diseases].
    Armas-Merino R; Wolff C; Soto R; Jirón MI; Parraguez A
    Rev Med Chil; 1999 Oct; 127(10):1240-54. PubMed ID: 10835742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C virus-associated type II mixed cryoglobulinemia vasculitis complicated with membranous proliferative glomerulonephritis.
    Lo KY; Chen CY; Lee CS
    Ren Fail; 2009; 31(2):149-52. PubMed ID: 19212913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extrahepatic manifestations of hepatitis C.
    Palekar NA; Harrison SA
    South Med J; 2005 Oct; 98(10):1019-23. PubMed ID: 16295816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relation between infection and autoimmunity in mixed cryoglobulinemia.
    Ferri C; Zignego AL
    Curr Opin Rheumatol; 2000 Jan; 12(1):53-60. PubMed ID: 10647955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Extrahepatic manifestations of chronic viral liver diseases].
    Aprosina ZG; Serov VV; Krel' PE; Ignatova TM
    Arkh Patol; 1999; 61(5):51-5. PubMed ID: 10598263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The spectrum of extrahepatic manifestations in hepatitis C virus infection.
    Hadziyannis SJ
    J Viral Hepat; 1997 Jan; 4(1):9-28. PubMed ID: 9031061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
    Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
    J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cryoglobulinemia and hepatitis C virus infection].
    Garini G; Catellani W; Manganelli P; Buzio C
    Recenti Prog Med; 2001 Jan; 92(1):54-62. PubMed ID: 11260973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral diseases associated with hepatitis C virus infection. Part 1. sialadenitis and salivary glands lymphoma.
    Carrozzo M
    Oral Dis; 2008 Mar; 14(2):123-30. PubMed ID: 18208477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection.
    El-Serag HB; Christie IC; Puenpatom A; Castillo D; Kanwal F; Kramer JR
    Aliment Pharmacol Ther; 2019 Jun; 49(11):1442-1447. PubMed ID: 30932218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetic nephropathy with concurrent hepatitis C virus infection related membranoproliferative glomerulonephritis.
    Ramesh Prasad GV; Bastacky S; Johnston JR
    Clin Nephrol; 1999 Jan; 51(1):50-3. PubMed ID: 9988147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis C virus-associated extrahepatic manifestations: a review.
    Sène D; Limal N; Cacoub P
    Metab Brain Dis; 2004 Dec; 19(3-4):357-81. PubMed ID: 15554428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Presence of hepatitis C virus in renal tissue in membranoproliferative glomerulonephritis and cryoglobulinemia].
    Tormo A; Rivera F; Muñoz C; Trigueros M
    Nefrologia; 2003; 23(2):165-8. PubMed ID: 12778882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.